Fiduciary Group LLC Amgen Inc Transaction History

Fiduciary Group LLC

  • $971 Million
  • Q3 2024

A detailed history of Fiduciary Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Fiduciary Group LLC holds 31,975 shares of AMGN stock, worth $8.45 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
31,975
Previous 32,385 1.27%
Holding current value
$8.45 Million
Previous $10.1 Million 1.82%
% of portfolio
1.06%
Previous 1.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$309.38 - $337.38 $126,845 - $138,325
-410 Reduced 1.27%
31,975 $10.3 Million
Q2 2024

Aug 08, 2024
SELL
$262.75 - $319.31 $143,987 - $174,981
-548 Reduced 1.66%
32,385 $10.1 Million
Q1 2024

May 13, 2024
SELL
$268.87 - $324.56 $120,453 - $145,402
-448 Reduced 1.34%
32,933 $9.36 Million
Q4 2023

Feb 05, 2024
SELL
$255.7 - $288.46 $723,119 - $815,764
-2,828 Reduced 7.81%
33,381 $9.61 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $41,543 - $51,577
-190 Reduced 0.52%
36,209 $9.73 Million
Q2 2023

Jul 27, 2023
BUY
$214.27 - $253.37 $1,285 - $1,520
6 Added 0.02%
36,399 $8.08 Million
Q1 2023

May 15, 2023
BUY
$225.79 - $275.2 $35,449 - $43,206
157 Added 0.43%
36,393 $8.8 Million
Q1 2023

May 15, 2023
BUY
$225.79 - $275.2 $32,965 - $40,179
146 Added 0.4%
36,539 $8.83 Million
Q4 2022

Feb 07, 2023
SELL
$229.03 - $291.01 $119,095 - $151,325
-520 Reduced 1.41%
36,236 $9.52 Million
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $99,211 - $111,892
442 Added 1.22%
36,756 $10.7 Million
Q2 2022

Aug 12, 2022
SELL
$230.71 - $256.74 $78,902 - $87,805
-342 Reduced 0.93%
36,314 $8.84 Million
Q1 2022

May 13, 2022
BUY
$219.27 - $242.57 $204,578 - $226,317
933 Added 2.61%
36,656 $8.82 Million
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $13,126 - $15,021
-66 Reduced 0.18%
35,723 $8.04 Million
Q3 2021

Oct 27, 2021
BUY
$212.27 - $248.7 $544,897 - $638,412
2,567 Added 7.73%
35,789 $7.47 Million
Q2 2021

Aug 05, 2021
BUY
$233.58 - $259.14 $191,769 - $212,753
821 Added 2.53%
33,222 $7.59 Million
Q1 2021

May 03, 2021
BUY
$221.91 - $258.6 $357,718 - $416,863
1,612 Added 5.24%
32,401 $7.77 Million
Q4 2020

Feb 12, 2021
BUY
$216.38 - $257.67 $149,734 - $178,307
692 Added 2.3%
30,789 $7.24 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $2,581 - $2,870
11 Added 0.04%
30,097 $7.65 Million
Q2 2020

Aug 14, 2020
BUY
$197.81 - $242.74 $110,971 - $136,177
561 Added 1.9%
30,086 $7.1 Million
Q1 2020

May 11, 2020
BUY
$182.24 - $241.7 $151,441 - $200,852
831 Added 2.9%
29,525 $5.99 Million
Q4 2019

Feb 14, 2020
BUY
$189.21 - $243.2 $50,329 - $64,691
266 Added 0.94%
28,694 $6.92 Million
Q3 2019

Nov 13, 2019
BUY
$174.11 - $208.62 $373,814 - $447,907
2,147 Added 8.17%
28,428 $5.5 Million
Q2 2019

Aug 05, 2019
BUY
$166.7 - $195.41 $586,617 - $687,647
3,519 Added 15.46%
26,281 $4.84 Million
Q1 2019

May 08, 2019
BUY
$180.87 - $203.88 $62,219 - $70,134
344 Added 1.53%
22,762 $4.32 Million
Q4 2018

Feb 13, 2019
BUY
$178.4 - $208.25 $274,200 - $320,080
1,537 Added 7.36%
22,418 $4.36 Million
Q3 2018

Oct 18, 2018
BUY
$185.29 - $208.89 $141,376 - $159,383
763 Added 3.79%
20,881 $4.33 Million
Q2 2018

Aug 02, 2018
BUY
$166.05 - $186.51 $50,313 - $56,512
303 Added 1.53%
20,118 $3.71 Million
Q1 2018

May 14, 2018
BUY
$169.43 - $198.0 $220,259 - $257,400
1,300 Added 7.02%
19,815 $3.38 Million
Q4 2017

Feb 02, 2018
BUY
$168.79 - $188.59 $281,204 - $314,190
1,666 Added 9.89%
18,515 $3.22 Million
Q3 2017

Nov 13, 2017
BUY
$167.29 - $191.0 $2.82 Million - $3.22 Million
16,849
16,849 $3.14 Million

Others Institutions Holding AMGN

# of Institutions
3,121
Shares Held
407M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email